Nicole R. Hadas, SVP, General Counsel, Secretary at Akebia Therapeutics, Inc. (AKBA), sold 1,556 shares at $8.95 ($14K) on 2016-10-01, disclosed to the SEC on 2016-10-04.
Open-market sale of $14k AKBA by SVP, General Counsel, Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AKBA | SELL | 2024-02-29 | $11K | — | Filing → |
| AKBA | SELL | 2023-05-25 | $154K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $11K | — | Filing → |